Actieve farmaceutische ingrediënten
Progestageen en oestrogeen | |||
productnaam | Specificatie | Goedgekeurd | CAS-nr. |
progesteron | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Medroxyprogesteronacetaat | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrolacetaat | CP/EP/USP | DMF onder Filing | 595-33-5 |
Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
Cyproteronacetaat | CP/EP | CEP/TGA/GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | DMF/GMP/CEPin-proces | 797-63-7 |
Drospirenon | EP/USP | DMF onder Filing | 67392-87-4 |
Gestodeen | CP/EP | DMF/GMP | 60282-87-3 |
oestradiol | CP/EP/USP | DMF | 50-28-2 |
oestriool | CP/EP/USP | Onder O&O | 50-27-1 |
Ethinylestradiol | CP/EP/USP | DMF/GMP | 57-63-6 |
Estradiol Valeraat | CP | DMF onder Filing | 979-32-8 |
Tibolon | CP/EP | DMF | 5630-53-5 |
Dienogest | EP | DMF onder Filing | 65928-58-7 |
Fulvestrant | EP/USP | Onder O&O | 129453-61-8 |
androgeen | |||
productnaam | Specificatie | Goedgekeurd | CAS-nr. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/DMF | 164656-23-9 |
Abirateronacetaat | CP/USP | DMF | 154229-18-2 |
Testosteron | CP/EP/USP | DMF/CEP in behandeling | 58-22-0 |
Testosteronundecanoaat | CP | DMF onder Filing | 5949-44-0 |
Testosteron Cypionate | USP | DMF onder Filing | 58-20-8 |
DHEA (prasteron) | FP/Inhouse | DMF/WC/Kosjer | 53-43-0 |
Corticaal hormoon | |||
productnaam | Specificatie | Goedgekeurd | CAS-nr. |
Budesonide | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonide | USP | DMF | 638-94-8 |
eplerenon | EP | CEP/FDA | 107724-20-9 |
Methylprednisolon | CP/EP/USP | DMF/WC | 83-43-2 |
MethylprednisolonHemisuccinaat | CP/EP/USP | DMF/WC | 2921-57-5 |
Fluticasonpropionaat | CP/EP/USP | DMF | 80474- 14-2 |
Fluticasonfuroaat | In huis | Onder O&O | 397864-44-7 |
Mometasonfuroaat | CP/EP/USP | Onder O&O | 83919-23-7 |
anderen | |||
productnaam | Specificatie | Goedgekeurd | CAS-nr. |
Oxcarbazepine | CP/EP/USP | CEP/DMF/GMP | 28721-07-5 |
Eslicarbazepine-acetaat | In huis | DMF onder Filing | 236395-14-5 |
ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
ValganciclovirHydrochloride | USP | DMF onder Filing | 175865-59-5 |
Oseltamivir Fosfaat | CP/EP/USP | DMF | 204255-11-8 |
Nintedanib-esylaat | In huis | DMF | 656247-18-6 |
Revefenacin | In huis | DMF bezig | 864750-70-9 |
Mirabegron | In huis | DMF bezig | 223673-61-8 |
Cariprazine-hydrochloride | In huis | DMF bezig | 1083076-69-0 |
Lasmiditan Succinaat | In huis | DMF bezig | 439239-92-6 |
Luliconazol | In huis | DMF bezig | 187164-19-8 |
productnaam | Specificatie | Goedgekeurd | CAS-nr. |
16α-Hydroxyprednisolon | Min 99,0% | DMF | 13951-70-7 |
16α-Hydroxyprednisolonacetaat | Min98,0% | DMF | 86401-80-1 |
21-Acetoxy-11β-hydroxypregna-1,4,16-trieen-3,20-dion | Min98,0% | TP | 3044-42-6 |
DHEA (prasteron) | Min 99,0% | DMF/WC | 53-43-0 |
DHEA-acetaat (Prasteron-acetaat) | Min 99,0% | DMF | 853-23-6 |
epiandrosteron | Min 99,0% | TP | 481-29-8 |
Abirateron | In huis | DMF | 154229-19-3 |
Triacetyl-ganciclovir | Min 98,5% | TP | 86357-14-4 |
Mono-acetyl ganciclovir | Min 97% | TP | 194254-40-0 |
16-Dehydropregnenolonacetaat ï¼16-DPAï¼ | Min 99,0% | TP | 979-02-2 |
Pregnenolonacetaat | Min98,0% | TP/ Koosjer | 1778-02-5 |
Pregnenolone | Min 99,0% | TP/koosjer | 145-13-1 |
3-Oxo-4-androsten-17β-carbonzuur | Min 99,0% | TP | 302-97-6 |
4-aza-5α-androstan-3-oxo-17β-carbonzuur | Min98,0% | DMF | 103335-55-3 |
4-aza-5α-androstan-1-een-3-oxo-17β-carbonzuur | Min98,0% | DMF | 104239-97-6 |
N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide | Min98,0% | DMF | 98319-24-5 |
6-chloor-1α-chloormethyl-3,20-dioxo-pregna-4,6-dien-17α-acetoxy | Min98,0% | DMF | 17183-98-1 |
Estrone | USP36 | TP | 53-16-7 |
Flumethason | Min98,0% | TP | 2135-17-3 |